Treatment with 10058-F4 for 24 hours in both ovarian cancer cells resulted in a significant decrease in mitochondria ROS levels (Figure 4B), suggesting 10058-F4 may inhibit the mitochondrial electron transport chain through the reduction of the c-Myc and Max interaction (21). This evidence concerns the gene MYC and ovarian carcinoma.